Buy stop for MRNAPennant formation with strong bullish morning star pattern filling up the mini exhaustion gap may indicate the bear is short-lived. But I'm waiting to buy stop at US$147.07
MRNA trade ideas
MRNA, price trend reversalThough MRNA has been generally overbought in the past few weeks, the market seems to be rejecting the low prices of the upper 130's. Fundamental speculators valuation is near 150, so we can expect a distinct bounce back in the upcoming days, and in addition to this, we expect good news regarding the FDA approving their vaccine as new public health data comes to light.
MRNA short termMRNA is testing support.
It should break out of the pennant soon.
Taking into account the news, I think the break out will be on a positive note.
"The U.S. Food and Drug Administration released a 54-page document outlining Moderna’s (MRNA) request for an emergency use authorization (EUA) Tuesday, bringing the biotech one step closer to the finish line.
Though it is widely anticipated that an EUA is issued by the weekend, based on the precedent set by Pfizer (PFE) and BioNTech (BNTX) last week, the exact timeline still remains unclear. The FDA’s vaccine advisory committee is slated to meet December 17 to vote on recommending authorization of the vaccine in adults 18 and older."
Adding to my position now.
MRNA just sold it at $137.23 I could be wrong, hard to say...MRNA just sold it at $137.23 I could be wrong, hard to say good bye.
Moderna nears FDA approval - what's next? #MRNA got a positive report of FDA expert commission on its covid vaccine today.
Committee meeting is scheduled for Thursday and vaccine approval may be granted starting from Friday.
It's going to be the most expensive vaccine of all so the sale numbers won't be of a global scale.
Way up to $200 for the #MRNA stock is technically pathed through the correction at $140.
MRNA Blow Off Top ConfirmedMRNA broke out of $100 hitting $178 within 4 days on high volume and multiple gap ups. This is significant evidence of a blow off top. Afterwards, we printed a daily bullish engulfing pattern then corrected upwards for 5 days before printing another daily engulfing pattern. The target is $100, which completes the blow off top move and the 1.618 extension of the Wave A move. Blow off tops have sharp moves and just as sharp reversals. I'd expect to see $100 by next week.
MRNA closely respecting fib retracementToday MRNA broke trend as the triangle price action (in yellow) squeezed in consolidation when the markets corrected. So far, the daily chart has been responsive to its fib retracement, most recently finding support at the 38.2% level of 147.66. Based on the sector I remain bullish, with support at 147.66 and resistance at 159.20 (the latter which was proven intraday and AH). If the price can cross this then next resistance is 177.85 at its recent 52 week high. If there is a selloff tomorrow next support is at 143.25 (in red).
mrna short the news?Very apparent, high volume rejection candle and buying pressure is dying up the wall of worry. To support we go?
looking to short $MRNAI don't feel the hype about vaccine play. The big drop gives me confidence that this stock is overhyped. Looking to short
Moderna Stock Analysis - MRNAPrices are moving in a bullish trend (very fast/very steep)- the best option would be to hold and wait the end of a possible price retracement/set back before going long to reach the target price of 180 USD.
NASDAQ:MRNA
MODERNA INC. BULLISHA potential outbreak to the upside on MRNA to complete wave (5) of ((3)) before correction to the fourth wave (4).
MRNA Fibonacci AnalysisWith MRNA looking to be a successful vaccine, I'm putting MRNA price target of 227.90 of course with an exit around 225. Looking for a breakout of the symmetrical triangle for entry tomorrow.
Will Moderna save the world ?We don't know if the hype is over around MRNA.
It has probably finished its 5-wave impulse and will need to settle down in correction.
There is support zone in the range 87-103 formed by previous price highs and some Fibo levels as seen on the chart.
From the fundamental point of view we could compare Moderna with some other biotechs: AMGN, GILD, VRTX, REGN, ILMN, BIIB.
Their P/S ratios (Price to Sale) are in the range from 3.50 to 14.50.
Big names like GSK, PFE, MRK make 5-7bn in all vaccine sales per year.
If MRNA makes $2bn in sales, at P/S=15 their Market Cap should be around $30bn --> $77 per share.
SHORT MRNA $150Shorts in at $150 gl bandwagon pump and dump scam MRNA.
Give it a few days until the negative news start piling.
Mr krabs
$MRNA$MRNA had an amazing run and finally cooled off at ATH. It has the potential to touch the $130.55 mark and retrace back up. It's over extended and will come back inside the Bollinger band in the next few days as it consolidates.
